News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biothera To Present Phase 2b NSCLC Data At ESMO 2014 European Lung Cancer Conference


3/27/2014 7:01:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biothera will present data from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) at the European Society for Medical Oncology’s 2014 European Lung Cancer Conference on March 28 in Geneva, Switzerland.

The company will give a presentation about its randomized trial in patients with previously untreated advanced NSCLC evaluating Biothera’s immunotherapy drug, Imprime PGG®.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES